Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Depreciation and Depletion (2023 - 2024)

Historic Depreciation and Depletion for Seres Therapeutics (MCRB) over the last 2 years, with Q3 2024 value amounting to $333000.0.

  • Seres Therapeutics' Depreciation and Depletion changed N/A to $333000.0 in Q3 2024 from the same period last year, while for Dec 2024 it was $989000.0, marking a year-over-year change of. This contributed to the annual value of $989000.0 for FY2024, which is 5101.54% down from last year.
  • Seres Therapeutics' Depreciation and Depletion amounted to $333000.0 in Q3 2024.
  • Seres Therapeutics' 5-year Depreciation and Depletion high stood at $551000.0 for Q4 2023, and its period low was $328000.0 during Q1 2024.